Digbi Health
Digbi Health is a precision biology digital therapeutics company providing personalized chronic-disease care (obesity, type 2 diabetes, GI, and mental health) by integrating genetic, gut microbiome, blood biomarker, and CGM data for self-insured employers, health plans, and individual consumers.
- Company typePrivate
- Founded2017
- HeadquartersMountain View, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What Digbi Health does
Digbi Health (legal entity FOOD RX AI INC.) is a precision biology digital therapeutics company headquartered at 800 El Camino Real West, Mountain View, California. Founded in 2017 by Ranjan Sinha, the company targets chronic metabolic, gastrointestinal, and mental-health conditions — primarily obesity, type 2 diabetes, IBS/GERD, and anxiety — that disproportionately drive employer healthcare spend. Its core offering is a multi-modal personalization platform that combines at-home genetic testing (600K variants via saliva), gut-microbiome analysis (stool swab through CLIA-compliant partner Akesogen), blood biomarkers, and continuous glucose monitor data into a unified member profile driving food-as-medicine recommendations.
The product portfolio spans Digbi Cares (obesity/metabolic/digestive), Digbi Digestive (GI-specific), Digbi Control (weight-loss subscription with personalized prebiotics at $68.99/month), and the GLP Compass suite — including GLP-Fit (Sep 2023) and Digbi RxFund (Mar 2026) — that integrates GLP-1 medication access and lifecycle management. A consumer subscription layer ($499 Digbi Cares one-time, or $45.08/month via Affirm financing) sits alongside a B2B enterprise channel with self-insured employers, health plans, and TPAs priced on milestone-based contracts with 100% of fees at risk against ROI claims.
Digbi monetizes through enterprise subscriptions (custom annual contracts with ROI guarantees, 9X actuarially validated ROI and $15,480 PMPY savings reported across seven employers), direct-to-consumer subscriptions and one-time kit sales, and GLP-1 transaction economics via the RxFund platform. Reported outcomes include 9.7% average weight loss without drugs, 18% with GLP-1s, 84% GI symptom improvement, 1.2% HbA1c reduction, and 63% mental-health improvement. Named enterprise customers include Blue Shield of California (23,500+ Wellvolution members), County of Ventura, and 300+ self-insured employers; strategic partners include Novo Nordisk, LabCorp, Collective Health, Health Transformation Alliance, Personify Health, and Dexcom.
Digbi Health firmographics
Firmographics- Name
- Digbi Health
- Legal name
- FOOD RX AI INC.
- Website
- https://digbihealth.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Digbi Health is a precision biology digital therapeutics company providing personalized chronic-disease care (obesity, type 2 diabetes, GI, and mental health) by integrating genetic, gut microbiome, blood biomarker, and CGM data for self-insured employers, health plans, and individual consumers.
- Ownership category
- akta.pro rank
Digbi Health industry classification
Industry- Product category
- Digital Therapeutics
- NAICS
- Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Offices of Other Health Practitioners (6213)
- SIC
- Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
- akta.pro secondary industries
- Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD), Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ), Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH)
Keywords
Where Digbi Health is headquartered
LocationHeadquarters
- HQ city
- Mountain View
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Digbi Health business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain
Revenue model
- Employer Health Benefits Contracts: Digbi Health generates revenue through B2B contracts with self-insured employers, health plans, and TPAs. Pricing is structured with milestone-based fees at risk for ROI, with claims-based transparent reporting. Employers pay for obesity, GI, cardiometabolic care, and GLP-1 management programs as part of employee benefits.
- Individual Consumer Subscriptions: Direct-to-consumer revenue from individual members purchasing programs like Digbi Cares ($499 one-time for gut kit + gene kit + meal planner) with monthly health tracking and coaching. Additional subscription tiers include personalized prebiotics at $68.99/month.
- GLP-1 Medication Fulfillment: Revenue from GLP Compass platform facilitating GLP-1 prescriptions and fulfillment across PBM, Direct to Employer, Employee Cash Pay, and 340B channels, with employer subsidies and cash-pay pathways through Digbi RxFund.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Monthly | Digbi Cares - Food-As-Medicine Program |
| Subscription | Monthly | Digbi Control - Weight Loss Program |
| Subscription | Annual | Employer/Enterprise Contracts |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels8 records
Digbi Health product offering
Product offeringCore offering
Digbi Health operates a Precision Biology digital therapeutics platform that combines at-home genetic and gut microbiome testing with blood biomarkers and continuous glucose monitor data to deliver personalized food-as-medicine care programs for obesity, type 2 diabetes, GI disorders, and cardiometabolic conditions. The company sells standalone consumer programs (Digbi Care, Digbi Control, Digbi Digestive), GLP-1 medication management offerings (GLP Compass, GLP-Fit, Digbi RxFund), and B2B employer/health plan contracts with ROI guarantees. Services include telehealth consultations, dedicated coaching, mobile app tracking, and integration with Apple/Google Health, Dexcom CGM, and Fitbit devices.
Product overview
Digbi Health operates as a multi-product digital therapeutics platform built around its proprietary Precision Biology™ framework. The core portfolio consists of two primary consumer programs—Digbi Cares (covering obesity, metabolic, and digestive health) and Digbi Digestive (focused on gastrointestinal care)—complemented by the weight-loss-specific Digbi Control offering. GLP Compass™ and GLP-Fit™ add GLP-1 medication management capabilities to the platform, while Digbi RxFund™ introduces financial pathways for employer-subsidized and cash-pay GLP-1 access. For employers, the platform consolidates multiple point solutions into a single precision care solution with ROI guarantees.
Differentiator
Problem solved
Functional benefit
Brands
- Digbi Cares: Food-as-Medicine care program for obesity, metabolic and digestive illnesses combining genetics, gut microbiome, and lifestyle interventions.
- GLP Compass
- Digbi Control
- Digbi Digestive
- Digbi RxFund
- GLP-Fit
Products and services
- Digbi Care (Digbi Cares) Food-as-Medicine care program for adults with obesity, metabolic, and digestive illnesses that combines at-home gut-biome and genetic tests, screening of 65 blood biomarkers, connected devices (CGM, BP, body composition scale), biology-based food and lifestyle guidance, dedicated 24x7 coaching, and access to a private member community.
- Digbi Control Subscription-based weight loss program (~$68.99/month) that uses gut microbiome and genetics-based digital care to identify and target root causes of obesity; includes DNA and gut test kits, personalized prebiotics, genetic nutrition and fitness reports, probiotic report, Digbi Mobile App, and dedicated coaching.
- Digbi Digestive Digestive health program for adults with IBS, GERD, bloating, constipation, and related GI conditions that integrates gut microbiome and DNA-based personalized recommendations with monitoring, diagnostics, care coordination, and community support.
- GLP Compass™ GLP-1 medication management program combining GLP-1 prescriptions with Precision Biology care, including doctor access, labs, prescription fulfillment, side effect management (nausea, diarrhea, hair loss, muscle loss), and personalized care to minimize weight rebound after drug discontinuation; fulfillment across PBM, Direct to Employer, Employee Cash Pay, and 340B channels.
- Digbi RxFund™ Financial innovation that gives employers and employees access to GLP-1 medications through subsidized, cash-pay, and traditional PBM pathways, creating predictable costs and supporting the full lifecycle of GLP-1 therapy in tandem with Precision Biology care.
- GLP-Fit™ Program Program that expands the Precision Biology platform to incorporate GLP-1-based personalized care for obesity, combining GLP-1 medication management with Digbi's biology-based nutrition, coaching, and mobile tracking.
- Digbi Health Employer Program Employer-facing digital care solution that consolidates obesity, cardiometabolic, diabetes, GI, and GLP-1 management for self-insured employers, health plans, and TPAs with simple contracting, minimal data exchange, turnkey claims billing, milestone-based pricing, and 100%-fees-at-risk ROI guarantees.
Quantifiable outcome
- 9.7% average weight loss without drugs; 18% with drugs
- +14 more outcomes
Companies that use Digbi Health
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Digbi Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability4 records
Feature5 records
Digbi Health partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core and minor.
- Novo NordiskcoreNovo Nordisk partnership focuses on precision biology for obesity prevention. Digbi Health's GLP Compass platform integrates with Novo Nordisk's GLP-1 medications, using precision biology to determine optimal GLP therapy and prevent unnecessary drug costs. ~30% of GLP-eligible employees choose not to start the drug through this program, delivering cost savings.
- LabCorpcoreLabCorp partnership for laboratory testing services supporting Digbi Health's diagnostic capabilities including blood markers and metabolic panels integrated into the precision biology platform.
- Health Transformation AlliancecorePartnership with Health Transformation Alliance for distribution of Digbi Health's precision biology programs to employer members.
- Northwell HealthminorPartnership with Northwell Health for research collaboration and healthcare delivery integration.
- Collective HealthcoreIntegration with Collective Health's platform announced September 2023 to integrate precision biology in streamlined healthcare benefits administration.
- AkesogencoreCLIA-compliant laboratory partner Akesogen processes saliva samples for DNA sequencing and stool samples for gut microbiome analysis as part of Digbi Health's at-home testing kits.
- AffirmminorFinancing partner Affirm enables monthly payment options for Digbi Health programs starting at $45.08/month, expanding accessibility for individual consumers.
- StanfordminorResearch partnership with Stanford University in genetics and gut microbiome research.
- UCLA HealthminorAcademic partnership with UCLA Health for research collaboration in precision health.
- CDCminorCollaboration with CDC on public health research related to obesity and chronic disease.
- HIMSSminorPartnership with HIMSS for healthcare technology industry engagement and visibility.
- SoleraminorSolera health platform partnership for ecosystem integration and benefit navigation.
- LifeGroupsminorPartnership with LifeGroups for faith-based and community employer distribution.
- West Virginia UniversityminorAcademic partnership with WVU for research and workforce health programs.
- Dr. Ron Sinha / Cultural Health SolutionsminorCorporate wellness expert Dr. Ron Sinha serves as advisor and refers patients to Digbi Health programs.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Digbi Health competitors and assessment
Company assessmentDirect peers
- Virta Health: Direct competitor offering telehealth-based diabetes reversal and obesity care to employers and health plans, with validated clinical outcomes. Closest comparable in mission, business model, and B2B employer contracting with ROI guarantees.
- Omada Health: Chronic disease prevention platform (diabetes, hypertension, obesity) sold to employers and health plans via B2B contracts. Directly comparable in customer base, revenue model, and condition focus, though Omada is broader and more established.
- Calibrate: GLP-1-focused metabolic reset program combining medication with coaching for employer and consumer markets. Directly comparable GLP Compass offering and similar target buyer.
- Found: Weight care platform combining medication (including GLP-1s) with behavior change for consumers and employers. Comparable in chronic weight management and GLP-1 integration strategy.
- Solera Health: Digital health benefit navigation platform connecting employers and payers with chronic disease prevention programs. Listed as Digbi partner, but also a competitor routing members to various point solutions.
Broad incumbents
- Noom: Established consumer and employer weight management platform with massive user base and brand recognition. Comparable in employer benefit distribution and chronic weight management, though Noom is broader and less biology-focused.
- Livongo (Teladoc Health): Major chronic condition management platform (diabetes, hypertension, weight) under Teladoc, serving employers and health plans. Comparable enterprise customer base and chronic care focus, though far larger and less personalized.
- WW International (WeightWatchers): Established weight management brand now expanding into GLP-1 medication programs for employers and consumers. Comparable employer benefit distribution and weight management focus with stronger consumer brand.
Emerging players
- Zoe: Personalized nutrition platform combining gut microbiome, blood markers, and dietary tracking for consumer health. Comparable precision biology approach (microbiome + blood), though primarily DTC and less employer-focused.
- Levels Health: CGM-focused metabolic health platform for consumers and employers. Comparable in CGM integration and metabolic focus, though narrower in scope (CGM only, no genetics/microbiome).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Digbi Health social profiles
Digital presenceDigbi Health compliance and trust
Trust signalCompliance4 records
Digbi Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Digbi Health leadership team
Management profileNumber of profiles
Profiles10 records
Digbi Health funding detail
Funding detailFunding overview
Funding rounds10 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Digbi Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Digbi Health
What does Digbi Health do?
Digbi Health operates a Precision Biology digital therapeutics platform that combines at-home genetic and gut microbiome testing with blood biomarkers and continuous glucose monitor data to deliver personalized food-as-medicine care programs for obesity, type 2 diabetes, GI disorders, and cardiometabolic conditions. The company sells standalone consumer programs (Digbi Care, Digbi Control, Digbi Digestive), GLP-1 medication management offerings (GLP Compass, GLP-Fit, Digbi RxFund), and B2B employer/health plan contracts with ROI guarantees. Services include telehealth consultations, dedicated coaching, mobile app tracking, and integration with Apple/Google Health, Dexcom CGM, and Fitbit devices.
Is Digbi Health a public or private company?
Digbi Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Digbi Health founded?
Digbi Health was founded in 2017. It employs 11 to 50 people.
Where is Digbi Health based?
Digbi Health is headquartered in Mountain View, United States, in the North America region.
How does Digbi Health make money?
Three revenue lines are on record. Employer Health Benefits Contracts are the primary driver. The others are individual Consumer Subscriptions and GLP-1 Medication Fulfillment.
Who are Digbi Health's main competitors?
Direct peers on record are Virta Health, Omada Health, Calibrate, Found and Solera Health. Broad incumbents are Noom, Livongo (Teladoc Health) and WW International (WeightWatchers). Emerging players are Zoe and Levels Health.
Does Digbi Health have an API?
No public API is recorded for Digbi Health.
What industry is Digbi Health in?
Digbi Health's product category is Digital Therapeutics. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HLALADAD, Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN). Its NAICS code is 524292 and its SIC code is 8000.